摘要
目的:探讨复方丹参滴丸联合低分子肝素治疗冠心病心绞痛临床疗效及安全性。方法:选取我院2011年11月-2013年11月收治的冠心病心绞痛患者46例,随机分为实验组和对照组,每组各23例,对照组采用常规心绞痛药物治疗,实验组在对照组的基础上采用低分子肝素皮下注射及口服复方丹参滴丸联合疗法,统计治疗前后心绞痛症状、两组心电图改善效果以及两组凝血功能并判定效果。结果:治疗组的临床治疗效果以及心电图改善效果均高于对照组(P<0.05),两组的PT、APTT指标无统计学差异(P>0.05)。结论:复方丹参滴丸联合低分子肝素治疗冠心病不稳定型心绞痛效果显著,安全无副作用,值得临床推广使用。
Objective: To investigate clinical efficacy and safety of compound Danshen Diwan plus low molecular weight heparin on treating angina in CHD. Methods: 46 patients with angina were randomly divided into experimental group and control group, control group was treated with conventional medicine, experimental group was treated with compound Danshen Diwan and low molecular weight heparin more. Collecting symptom of angina pectoris, improvement effect of electrocardiogram, blood coagulation function in the two groups before and after the treatment, judging the clinical effects. Results: In experimental group, electrocardiogram and clinical treatment effect of improvement were higher than that in control group (P〈0.05). There was no statistical difference of PT, APTT indicators (P〉0.05). Conclusion: Compound Danshen Diwan plus low molecular weight heparin for angina in CHD were obviously effective and worthy of clinical application, had less side effects.
出处
《中医临床研究》
2014年第14期76-77,共2页
Clinical Journal Of Chinese Medicine
关键词
复方丹参滴丸
低分子肝素
冠心病
不稳定型心绞痛
Compound Danshen Diwan
Low molecular weight heparin
CHD
Unstable angina pectoris